抗VEGF角膜基质注药联合手术治疗假性翼状胬肉1例

doi:10.6040/j.issn.1673-3770.0.2021.400

摘要/Abstract

摘要： 目的分享1例抗VEGF角膜基质注药联合手术治疗假性翼状胬肉的临床疗效。方法复习1例老年男性患者的病例资料,因左眼被铁水烫伤继发睑球粘连及假性胬肉,行左眼假性胬肉切除+自体角膜缘干细胞结膜瓣移植+口唇黏膜移植+羊膜覆盖+眼睑成型术。在此之前左眼行2次羊膜移植术、睑裂缝合术及3次结膜下+角膜基质内抗VEGF注药术,术后抗感染治疗。结果术后1个月,左眼视力0.2,移植的唇黏膜及球结膜恢复血供,角膜局限性混浊,前房中深,虹膜无前后粘连,晶状体轻度混浊,眼底(-)。结论此病例较罕见,热烫伤后继发重度睑球粘连及假性翼状胬肉,治疗难度大。对于肥厚的假性翼状胬肉可先行抗VEGF角膜基质注药,待胬肉变薄后行手术治疗可取得较好的临床疗效。

关键词: 抗VEGF, 角膜基质注药, 铁水烫伤, 假性翼状胬肉, 羊膜移植, 角膜缘干细胞移植, 唇黏膜移植

Abstract: Objective The objective of the study is to investigate the clinical efficacy of anti-vascular endothelial growth factor(VEGF)corneal matrix injection combined with operation in the treatment of pseudygium. Methods The case data of one elderly male patient, who developed palpebral adhesion and pterygium after scalding with molten iron in the left eye, were reviewed. The patient underwent left pterygium excision, autologous limbal stem cell conjunctival flap transplantation, oral mucosa transplantation, amniotic membrane covering, and blepharoplasty. Prior to these, the left eye was treated with two amniotic membrane transplantations, an eyelid fissure, and three subconjunctival and intrastromal anti-VEGF injections. Results One month after the operation, the visual acuity of the left eye was 0.2, the blood supply of the transplanted labial mucosa and bulbar conjunctiva was restored, the cornea was locally cloudy, the anterior chamber was deep, the iris had no adhesion, the lens was slightly cloudy, fundus(-). Conclusion This is a rare case of severe palpebral adhesion and pseudopterygium secondary to a heat scald, which is difficult to treat. For hypertrophic pseudopterygium, anti-VEGF corneal matrix injection can be administered first, and operation after pterygium thinning can achieve good clinical efficacy.

Key words: Anti-VEGF, Corneal stromal injection, Scalding with molten iron, Pseudopterygium, Amniotic membrane transplantation, Limbal stem cell transplantation, Labial mucosa transplantation

中图分类号:

R779.6

潘彦丽,李元彬. 抗VEGF角膜基质注药联合手术治疗假性翼状胬肉1例[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 96-99.

PAN Yanli, LI Yuanbin. Treatment of pseudygium with anti-VEGF corneal matrix injection combined with operation: a case report[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 96-99.

参考文献

[1] 白冰,方晏红. 中重度眼化学伤急性期处理及羊膜移植的疗效观察[J].国际眼科杂志,2014,14( 4): 714-716. doi: 10.3980 /j. issn.1672-5123.2014.04.40. BAI Bing, FANG Yanhong. Clinical observation of acute treatment of moderate and severe ocular chemical injury and amniotic membrane transplantation[J]. International Journal of Ophthalmology, 2014, 14(4): 714-716. doi: 10.3980 / J.issn.1672-5123.2014.04.40.
[2] 刘家琦, 李凤鸣. 实用眼科学[M]. 3版. 北京: 人民卫生出版社,2020.
[3] 彭丽, 谢青, 陈敏华. 抗VEGF治疗在眼科的临床意义及研究进展[J]. 国际眼科杂志, 2020, 20(2):282-285. doi:10.3980/j.issn.1672-5123.2020.2.20. PENG Li, XIE Qing, CHEN Min-Hua. Clinical significance and recent research advances of anti-VEGF treatment in ophthalmology[J]. International Eye Science, 2020, 20(2): 282-285. doi:10.3980/j.issn.1672-5123.2020.2.20.
[4] Gal-Or O, Livny E, Sella R, et al. Efficacy of subconjunctival aflibercept versus bevacizumab for prevention of corneal neovascularization in a rat model[J]. Cornea, 2016, 35(7): 991-996. doi:10.1097/ICO.0000000000000849.
[5] Chang JH, Garg NK, Lunde E, et al. Corneal neovascularization: an anti-VEGF therapy review[J]. Surv Ophthalmol, 2012, 57(5): 415-429. doi:10.1016/j.survophthal.2012.01.007.
[6] Keating AM, Jacobs DS. Anti-VEGF treatment of corneal neovascularization[J]. Ocul Surf, 2011, 9(4): 227-237. doi:10.1016/s1542-0124(11)70035-0.
[7] Ucgul Rukiye Kilic, Celebi Serdal, Yilmaz Niyazi Samet, et al. Intrastromal versus subconjunctival anti-VEGF agents for treatment of corneal neovascularization: a rabbit study[J]. Eye, 2021, 35(11): 3123-3130. doi:10.1038/s41433-020-01347-3.
[8] Papathanassiou M, Theodoropoulou S, Analitis A, et al. Vascular endothelial growth factor inhibitors for treatment of corneal neovascularization: a meta-analysis[J].Cornea, 2013, 32(4): 435-444. doi:10.1097/ICO.0b013e3182542613.
[9] Nava-Castañeda A, Olvera-Morales O, Ramos-Castellon C, et al. Randomized, controlled trial of conjunctival autografting combined with subconjunctival bevacizumab for primary pterygium treatment: 1-year follow-up[J]. Clin Experiment Ophthalmol, 2014, 42(3): 235-241. doi:10.1111/ceo.12140.
[10] Ozgurhan EB, Agca A, Kara N, et al. Topical application of bevacizumab as an adjunct to recurrent pterygium surgery[J]. Cornea, 2013, 32(6): 835-838. doi:10.1097/ICO.0b013e3182772d4e.
[11] Sun Y, Zhang BW, Jia XH, et al. Efficacy and safety of bevacizumab in the treatment of pterygium: an updated meta-analysis of randomized controlled trials[J]. J Ophthalmol, 2018, 2018: 4598173. doi:10.1155/2018/4598173.
[12] Zeng W, Liu ZM, Dai HJ, et al. Anti-fibrotic, anti-VEGF or radiotherapy treatments as adjuvants for pterygium excision: a systematic review and network meta-analysis[J]. BMC Ophthalmol, 2017, 17(1): 211. doi:10.1186/s12886-017-0601-5.
[13] Mohamed TA, Soliman W, Fathalla AM, et al. Effect of single subconjunctival injection of bevacizumab on primary pterygium: clinical, histopathological and immunohistochemical study[J]. Int J Ophthalmol, 2018, 11(5): 797-801. doi:10.18240/ijo.2018.05.13.
[14] Sacchetti M, Rama P, Bruscolini A, et al. Limbal stem cell transplantation: clinical results, limits, and perspectives[J]. Stem Cells Int, 2018, 2018: 8086269. doi:10.1155/2018/8086269.
[15] 李楠钰, 张文佳, 胡竹林. 羊膜在眼表疾病治疗的研究进展[J]. 国际眼科纵览, 2019, 43(2): 94-99. doi:10.3760/cma.j.issn.1673-5803.2019.02.005. LI Nanyu, ZHANG Wenjia, HU Zhulin. Advances in the treatment of ocular surface diseases by amniotic membrane[J]. International Review of Ophthalmology, 2019, 43(2): 94-99. doi:10.3760/cma.j.issn.1673-5803.2019.02.005.
[16] 李保江, 李霞, 高晓唯, 等. 自体角膜缘干细胞分期移植治疗中重度眼部碱烧伤[J]. 国际眼科杂志, 2007, 7(5): 1444-1446. doi:10.3969/j.issn.1672-5123.2007.05.075. LI Baojiang, LI Xia, GAO Xiaowei, et al. Corneal limbus stem cell autograft for moderate-severe ocular alkaline burn by stages[J]. International Eye Science, 2007, 7(5): 1444-1446. doi:10.3969/j.issn.1672-5123.2007.05.075.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed